Blanket Purchase Agreement V797P2125D-36E79719A0011

Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, was awarded a single-award Indefinite Delivery Contract valued at $28.2 million by the Department of Veterans Affairs National Acquisition Center on June 7, 2021, for the supply of buprenorphine hydrochloride/naloxone hydrochloride sublingual tablets. The contract period of performance runs from June 7, 2021, through June 6, 2026, consisting of an initial one-year base period with four one-year option periods. This procurement...

The Department of Veterans Affairs awarded a single-award indefinite delivery contract to DR Reddy's Laboratories, Inc. to supply an estimated 140,000 boxes annually of various strengths of Buprenorphine/Naloxone Film Sublingual. The contract has a one-year base period of performance beginning February 4, 2020 with four one-year option periods and a potential value of $42,763,747.32. The original solicitation sought to establish a prime vendor contract to supply Buprenorphine/Naloxone Film...

Golden State Medical Supply, Inc. has been awarded a single-award Indefinite Delivery Contract by the VA National Acquisition Center for the supply of Buprenorphine HCL/Naloxone HCL sublingual tablets to support multiple federal healthcare systems. The contract, valued at $20.98 million, covers the base ordering period from June 8, 2026, through June 7, 2027, with four one-year option periods extending potential contract performance through June 7, 2030. The specific products procured include...

This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Amneal Pharmaceuticals of New York, LLC, a for-profit limited liability company. The $2,500,000 BPA is for the supply of the pharmaceutical drug sodium oxybate and does not utilize any set-asides. Amneal Pharmaceuticals has been awarded several other federal contracts and IDVs, primarily for the provision of specialized pharmaceutical products and services, including a $1,710,320...

This Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Nephron Sterile Compounding Center LLC on March 1, 2020, with a potential value of $2.5 million. The BPA is for specialized compounded intravenous solutions with no set-aside used. The period of performance extends through the last date to order of September 30, 2023. The BPA facilitates recurring orders for specific pharmaceutical products and supplies, including Phenylephrine HCI Injection,...

This Blanket Purchase Agreement, awarded on February 7, 2023, by the National Acquisition Center to Hikma Pharmaceuticals USA Inc. (formerly West-Ward Pharmaceuticals) with a ceiling value of $38.5 million, provides a single-award indefinite delivery vehicle for the procurement of sodium oxybate through December 17, 2025. No small business set-aside was utilized for this award. Sodium oxybate, marketed under the brand name XYREM, is a controlled pharmaceutical product used primarily in the...

This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Corcept Therapeutics Incorporated. The contract has a ceiling value of $3,700,000.00 and an ultimate completion date of September 5, 2024. The purpose of this BPA is to provide the agency with Korlym, a pharmaceutical drug. This BPA was established under the General Services Administration (GSA) Federal Supply Schedule 61-IB for Pharmaceuticals and Drugs. The contract is a single...

The Blanket Purchase Agreement was awarded as a single award by the Department of Veterans Affairs National Acquisition Center to Aimmune Therapeutics, Inc. The potential value of the BPA is $14 million. The BPA is for the procurement of Palforzia, which is intended to reduce the frequency and severity of allergic reactions to peanuts in patients aged 4 through 17 years. No set-aside was used in the awarding of this BPA. The period of performance for orders placed against the BPA extends through...

This Blanket Purchase Agreement, awarded to Kaleo, Inc. on August 29, 2023, establishes a single-award indefinite delivery vehicle with a ceiling value of $5,025.00 for the procurement of naloxone auto-injector products. The contract was funded by the National Acquisition Center, a civilian federal agency, and falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The agreement does not utilize any small business set-asides and carries an ultimate completion date of...

This Blanket Purchase Agreement, awarded to Amneal Pharmaceuticals of New York, LLC by the National Acquisition Center on April 21, 2026, establishes a single-award indefinite delivery vehicle with a ceiling value of $7.5 million and an ultimate completion date of April 20, 2027. The contract operates under the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and requires no set-aside designation, reflecting open competition for these specialized...